| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.25 | 0.003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |